STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

August 23, 2024

Period of Report

August 22, 2024

Accession Number

0001062993-24-015606